Quantcast

Latest Hepatic encephalopathy Stories

2009-04-28 06:00:00

The Company also Initiates the Phase 2b ASTUTE Clinical Trial for Mild Hepatic Encephalopathy SAN DIEGO, April 28 /PRNewswire/ -- Ocera Therapeutics, Inc., a privately held biopharmaceutical company, announced that data from its phase 2 study of AST-120 for the treatment of patients with low-grade hepatic encephalopathy was presented April 25th at the 44th Annual Meeting of the European Association for the Study of Liver Disease (EASL) in Copenhagen. The study showed that AST-120 was better...

2009-02-11 08:39:33

Liver cirrhosis is the seventh leading cause of death in the United States, taking 25,000 lives per year. It is often the result of alcohol over-consumption or exposure to hepatitis C, either of which can damage the liver and prevent it from filtering toxins. These toxins then accumulate in the blood stream and eventually reach the brain where they disrupt neurological and mental performance, a condition known as hepatic encephalopathy.Individuals with cirrhosis are also susceptible to a...

2008-11-05 18:00:23

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and operating results for the third quarter ended September 30, 2008. Total product revenue was $42.9 million for the third quarter of 2008, compared to $67.4 million for the third quarter of 2007. Total product revenue for the first nine months of 2008 was $118.2 million compared to $193.8 million for the first nine months of 2007. The decrease in total product revenue for the quarter and nine months was due to the...

2008-10-06 09:00:09

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the successful completion and outcome of its pivotal Phase 3 trial to evaluate the efficacy, safety and tolerability of rifaximin in preventing hepatic encephalopathy, or HE. This study demonstrates that the protocol-specified, intent-to-treat, primary endpoint comparison of a 6-month course of rifaximin at 550 mg dosed twice-a-day provides a highly statistically significant result in preventing HE, compared to placebo. The results...

2008-10-06 09:00:09

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced findings from two analyses of a Phase II clinical trial that demonstrate the utility of rifaximin, a non-absorbed, gut-selective antibiotic, in the treatment of patients with diarrhea-predominant irritable bowel syndrome (IBS). Data presented at the annual meeting of the American College of Gastroenterology (ACG) showed that patients treated with rifaximin demonstrated that the severity of baseline IBS symptoms of abdominal pain and...

2008-08-05 18:00:09

WALTHAM, Mass., Aug. 5 /PRNewswire-FirstCall/ -- Arbios Systems, Inc. (BULLETIN BOARD: ABOS) announced today that the Company is focusing its day-to-day operations exclusively on obtaining financing or consummating a strategic transaction. In order to preserve the Company's remaining cash resources, the Company's employees were released from employment, except for Shawn Cain, the Company's President and CEO, and Scott Hayashi, the Company's CFO, who will continue to provide services to...

2008-04-25 03:00:16

By Cotton, Ann Beemer Managing the renal diet can be daunting. End stage liver disease (ESLD) combined with dialysis dependency further increases the diet complexity. Protein, sodium, and calories are cornerstones of medical nutrition therapy (MNT) in ESLD but have differing therapeutic rationales from the renal diet. Medications play a central role in control of ESLD as they do with the patient on dialysis to control symptoms and promote quality of life. Malnutrition in ESLD may be more...

2006-08-09 15:06:53

NEW YORK (Reuters Health) - In patients with cirrhosis of the liver due to infection with hepatitis C virus (HCV), the presence of diabetes is associated with earlier onset and greater severity of liver or "hepatic" encephalopathy, according to results of a prospective study. Hepatic encephalopathy is a complication of cirrhosis of the liver. Toxic substances like ammonia that accumulate in the blood and impair the function of brain cells are believed to be contributing factors. Dr....


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related